Tesamorelin 5 mg
$42.00
British Dragon Tesamorelin 5 mg – Potent GHRH Analog
British Dragon Tesamorelin 5 mg is a synthetic analog of growth hormone-releasing hormone (GHRH), specifically the full-length GHRH (1-44) sequence with a chemical modification that enhances its resistance to enzymatic degradation. Each 2 mL vial contains 5 mg of lyophilized Tesamorelin, designed for reconstitution in research settings investigating metabolic function, body composition, and growth hormone regulation.
Tesamorelin acts on the pituitary somatotrophs to stimulate endogenous growth hormone release with greater potency and duration than shorter GHRH analogs. For researchers studying visceral adiposity and metabolic parameters, this peptide offers distinct advantages. Explore similar research compounds like Sermorelin 5 mg or Ipamorelin 5 mg.
What Makes British Dragon Tesamorelin Unique?
Tesamorelin contains a trans-3-hexenoic acid modification at the N-terminus, which confers resistance to dipeptidyl peptidase-4 (DPP-4) degradation, resulting in a longer half-life compared to unmodified GHRH (1-44). This modification allows for once-daily administration in research protocols while maintaining biological activity.
For metabolic research, Tesamorelin has been extensively studied for its effects on visceral adipose tissue and metabolic parameters. The 5 mg dosage provides sufficient material for extended research protocols investigating chronic GHRH analog administration. Researchers may also compare Tesamorelin with Sermorelin to evaluate differences between GHRH fragments and full-length analogs.
Benefits of British Dragon Tesamorelin for Research
- ✔ Full-length GHRH (1-44) analog with enhanced stability
- ✔ DPP-4 resistant for extended duration of action
- ✔ 5 mg lyophilized powder for reconstitution flexibility
- ✔ Suitable for subcutaneous administration research
- ✔ Relevant for metabolic and body composition studies
British Dragon Tesamorelin 5 mg is intended for laboratory research only. Not for human consumption or clinical use.
External research on Tesamorelin's mechanisms can be explored via PubMed for peer-reviewed studies.